Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Tagliati

Showing results (31-40 of 83) with videos related to

Pageof 9
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|March 16, 2019
Adrenoceptor agonists and antagonists and risk of Parkinson's diseaseHelia Maghzi, Elliot J Hogg, Echo Tan, et al.
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|November 14, 2015
Systematic Literature Review of AbobotulinumtoxinA in Clinical Trials for Blepharospasm and Hemifacial SpasmKhashayar Dashtipour, Jack J Chen, Karen Frei, et al.
Brain Sciences|January 8, 2020
Speech Intelligibility During Clinical and Low FrequencyJohn J Sidtis, Diana Van Lancker Sidtis, Ritesh Ramdhani, et al.
Frontiers in Computational Neuroscience|October 26, 2020
Steering the Volume of Tissue Activated With a Directional Deep Brain Stimulation Lead in the Globus Pallidus Pars Interna: A Modeling Study With Heterogeneous Tissue PropertiesSimeng Zhang, Michele Tagliati, Nader Pouratian, et al.
Frontiers in Neurology|October 25, 2021
Short- and Long-Term Effects of DBS on Gait in Parkinson's DiseaseHana Brozova, Isabelle Barnaure, Evzen Ruzicka, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 28, 2016
Neuropsychological outcomes from constant current deep brain stimulation for Parkinson's diseaseAlexander I Tröster, Joseph Jankovic, Michele Tagliati, et al.
Parkinsonism & Related Disorders|December 9, 2014
Constipation is reduced by beta-blockers and increased by dopaminergic medications in Parkinson's diseaseGennaro Pagano, Echo E Tan, Janelle M Haider, et al.
Journal of Neurology|March 6, 2025
Adrenergic blockers, statins, and non-steroidal anti-inflammatory drugs are associated with later age at onset in Parkinson's diseaseCamille Malatt, Helia Maghzi, Elliot Hogg, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|October 6, 2011
Therapeutic high-frequency stimulation of the subthalamic nucleus in Parkinson's disease produces global increases in cerebral blood flowJohn J Sidtis, Michele Tagliati, Ron Alterman, et al.
Frontiers in Neurology|June 14, 2021
Stimulation of the Subthalamic Nucleus Changes Cortical-Subcortical Blood Flow Patterns During Speech: A Positron Emission Tomography StudyJohn J Sidtis, Diana Van Lancker Sidtis, Vijay Dhawan, et al.
Pageof 9

Showing results (31-40 of 83) with videos related to

Sort By:
Pageof 9
Movement Disorders : Official Journal of the Movement Disorder Society|March 16, 2019
Adrenoceptor agonists and antagonists and risk of Parkinson's diseaseHelia Maghzi, Elliot J Hogg, Echo Tan, et al.
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|November 14, 2015
Systematic Literature Review of AbobotulinumtoxinA in Clinical Trials for Blepharospasm and Hemifacial SpasmKhashayar Dashtipour, Jack J Chen, Karen Frei, et al.
Brain Sciences|January 8, 2020
Speech Intelligibility During Clinical and Low FrequencyJohn J Sidtis, Diana Van Lancker Sidtis, Ritesh Ramdhani, et al.
Frontiers in Computational Neuroscience|October 26, 2020
Steering the Volume of Tissue Activated With a Directional Deep Brain Stimulation Lead in the Globus Pallidus Pars Interna: A Modeling Study With Heterogeneous Tissue PropertiesSimeng Zhang, Michele Tagliati, Nader Pouratian, et al.
Frontiers in Neurology|October 25, 2021
Short- and Long-Term Effects of DBS on Gait in Parkinson's DiseaseHana Brozova, Isabelle Barnaure, Evzen Ruzicka, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 28, 2016
Neuropsychological outcomes from constant current deep brain stimulation for Parkinson's diseaseAlexander I Tröster, Joseph Jankovic, Michele Tagliati, et al.
Parkinsonism & Related Disorders|December 9, 2014
Constipation is reduced by beta-blockers and increased by dopaminergic medications in Parkinson's diseaseGennaro Pagano, Echo E Tan, Janelle M Haider, et al.
Journal of Neurology|March 6, 2025
Adrenergic blockers, statins, and non-steroidal anti-inflammatory drugs are associated with later age at onset in Parkinson's diseaseCamille Malatt, Helia Maghzi, Elliot Hogg, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|October 6, 2011
Therapeutic high-frequency stimulation of the subthalamic nucleus in Parkinson's disease produces global increases in cerebral blood flowJohn J Sidtis, Michele Tagliati, Ron Alterman, et al.
Frontiers in Neurology|June 14, 2021
Stimulation of the Subthalamic Nucleus Changes Cortical-Subcortical Blood Flow Patterns During Speech: A Positron Emission Tomography StudyJohn J Sidtis, Diana Van Lancker Sidtis, Vijay Dhawan, et al.
Pageof 9